Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Renew membership to vote on Royal College status - RPS urges pharmacists

The historic vote on the Society’s proposed transition to the Royal College of Pharmacy opens on 13 March

join RPS by February 2025 for SRV

For the resolution to pass, two-thirds of participating members must vote in favour.


The Royal Pharmaceutical Society (RPS) is urging pharmacists to renew their membership by 28 February 2025 or join by this date to be eligible for the upcoming Special Resolution Vote (SRV) on its proposed transition to The Royal College of Pharmacy.


Under the current RPS Charter, regulations, and SRV Scheme, eligible voters include pharmacists who are or have been registered with the pharmacy regulator—either the General Pharmaceutical Council (GPhC) or the former Royal Pharmaceutical Society of Great Britain (RPSGB).

To participate, they must hold Member (MRPharmS) or Fellow (FRPharmS) status with the RPS on 28 February 2025.

Voting eligibility is not affected by a member’s location, retirement status, or current employment, as long as they meet the criteria.

However, Associate Members, Pharmaceutical Scientists (unless they hold MRPharmS or FRPharmS status), and student members are not eligible to vote.

The SRV, which seeks to amend the Society’s Royal Charter to facilitate its transition to a Royal College and registered charity, will open at 9 am on Thursday, 13 March, and close at 5 pm on Monday, 24 March 2025.

For the resolution to pass, two-thirds of participating members must vote in favour.

The proposed Charter amendments have undergone informal review and scrutiny by the Privy Council Office and Charity Commission to ensure compliance with charity law and regulatory recommendations.

Paul Bennett, chief executive of the RPS, emphasised the significance of membership renewal by 28 February, stating: “If it lapses or you are not a member by then, you won’t be able to participate in this historic vote on the Society’s proposed transition to Royal College status and the changes to our Royal Charter.”

He added that the proposed changes would help create “the stronger, louder voice that pharmacy deserves” and urged those considering membership to join by the deadline to ensure their participation.

More For You

Locum pharmacists in the UK work in a difficult environment, and many are dissatisfied with their jobs.

Locum pharmacists in the UK work in a difficult environment, and many are dissatisfied with their jobs.

iStock

Locums should stand up for their interests, say 'no' to unfair terms: PDA

The Pharmacists' Defence Association (PDA) has advised locum pharmacists to be vigilant about their interests and negotiate directly with their businesses, avoid working with digital platforms driven by algorithms, and be aware of regressive contract terms.

The not-for-profit organisation issued such an advisory following its survey of 1,300 UK locum pharmacists, which showed that they work in a difficult environment and that most are dissatisfied with their jobs.

Keep ReadingShow less
Wales ranked worst for second-trimester abortion access in the UK

Each year about 175 women travel from Wales to England for care

Wales ranked worst for second-trimester abortion access in the UK

A leading healthcare charity has revealed that Wales is the worst part of the United Kingdom for allowing surgical abortions for women.

Surgical abortion is the process removing pregnancy from the womb by inducing local anaesthesia, conscious sedation or general anaesthesia.

Keep ReadingShow less
The fund offers £150 per eligible child - for up to three children per household.

The fund offers £150 per eligible child - for up to three children per household.

Charity reopens funding to ease back to school financial pressures for community pharmacists

Community pharmacists struggling with the costs of their children going back to school can apply for funding from The Leverhulme Trade Charities Trust (LTCT)

The Trust is providing up to £100,000 of support to those working in a community pharmacy or are a registered pharmacist or pharmacy technician

Keep ReadingShow less
Germany's BioNTech to buy CureVac to boost cancer research

Both biotech companies have been working for years in the area of mRNA vaccines and treatments

Germany's BioNTech to buy CureVac to boost cancer research

Germany's BioNTech is buying domestic rival CureVac for $1.25 billion, bringing together two pharmaceutical firms specialised in mRNA technology with the goal of advancing cancer treatments.

BioNTech, which developed the first coronavirus vaccine to be approved in the West along with US pharmaceutical giant Pfizer, said the acquisition would "bring together complementary capabilities and leverage technologies".

Keep ReadingShow less
Amandeep Doll RPS  New Director of England

Amandeep Doll

RPS announces new director of England

Amandeep Doll has been named as the new director for England at the Royal Pharmaceutical Society (RPS).

The role of Director for England drives professional leadership for the pharmacy profession in England, and leads on national policy development and advocacy across England, in partnership with the English Pharmacy Board.

Keep ReadingShow less